The funding round was led by Interpublic Group and Olma Partners to support spatial computing and artificial intelligence development.
"The world of static 2D e-commerce is becoming archaic. User behavior is evolving and brands striving for distinction recognise the need to meet consumer demands for enriched, customisable experiences on the spatial web. This new round of investment reinforces the trust investors place in our mission to revolutionise digital landscapes, equipping businesses with engaging and immersive capabilities."
The funding round was led by JamJar Investments and brings the company's total money raised to £7.8m.
"Solo travel has continued to grow in popularity as people look to expand their horizons and make up for lost time, but in the last two years, we have also seen an increased appetite for building meaningful connections through travel. We’re proud to be doing our part in helping to make cities like London less isolated, with 80% Flashpackers staying in touch after their trip. The recent investment indicates the value in this growing trend and we’re incredibly excited to continue this success worldwide."
The funding round was led by The TRICAPITAL Syndicate to expand production and commercial reach.
"Beta Bugs has supplied its industry leading products to an increasing number of established and new entrant insect farmers in the UK and international markets. The company continues to develop its outstanding HiPer-Fly® breeding programme, which has demonstrated consistent increases in Black Soldier Fly genetic performance across multiple, economically valuable production traits."
Senzo Health has secured £1.4m in funding to further develop its Amplified Lateral Flow diagnostic technology.
"When a PCR test is able to pick something up early, we’re able to pick it up. Our limit of detection is somewhere between 1,000 and 10,000 times better than current lateral flow tests, much closer to PCR levels. What the market doesn’t need is another test that is just a screen on the front end … what we need are tests that are tests of record that can be acted on. That requires performance that is at the level of current central lab PCR tests,"
Northern Gritstone led the funding round, which will support the commercialisation of the company's carbon removal technology.
"There has never been a more critical time to take action – decisive action – against climate change than right now. This investment brings us one step closer to realising our mission of mitigating climate change by allowing our team to focus on scaling our technology. From our first meeting with Duncan and his team, we knew that our priorities and values are very much aligned so we’re very pleased to welcome Northern Gritstone as an investor. With their expertise in backing visionary companies in the North of England, I see a very bright future ahead of us."
